ID   IFIT3_HUMAN             Reviewed;         490 AA.
AC   O14879; Q99634; Q9BSK7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   18-JUN-2025, entry version 206.
DE   RecName: Full=Interferon-induced protein with tetratricopeptide repeats 3;
DE            Short=IFIT-3;
DE   AltName: Full=CIG49;
DE   AltName: Full=ISG-60;
DE   AltName: Full=Interferon-induced 60 kDa protein;
DE            Short=IFI-60K;
DE   AltName: Full=Interferon-induced protein with tetratricopeptide repeats 4;
DE            Short=IFIT-4;
DE   AltName: Full=Retinoic acid-induced gene G protein;
DE            Short=P60;
DE            Short=RIG-G;
GN   Name=IFIT3; Synonyms=CIG-49, IFI60, IFIT4, ISG60;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Foreskin;
RX   PubMed=9391139; DOI=10.1073/pnas.94.25.13985;
RA   Zhu H., Cong J.-P., Shenk T.;
RT   "Use of differential display analysis to assess the effect of human
RT   cytomegalovirus infection on the accumulation of cellular RNAs: induction
RT   of interferon-responsive RNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:13985-13990(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9828129; DOI=10.1006/geno.1998.5555;
RA   de Veer M.J., Sim H., Whisstock J.C., Devenish R.J., Ralph S.J.;
RT   "IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of
RT   interferon-stimulated genes.";
RL   Genomics 54:267-277(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yu M., Tong J., Mao M., Chen S., Chen Z.;
RT   "RIG-G, a novel gene induced by ATRA in acute promyelocytic leukemia cells,
RT   is a new member of the ISG family.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INDUCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH COPS5.
RX   PubMed=17050680; DOI=10.1073/pnas.0607830103;
RA   Xiao S., Li D., Zhu H.Q., Song M.G., Pan X.R., Jia P.M., Peng L.L.,
RA   Dou A.X., Chen G.Q., Chen S.J., Chen Z., Tong J.H.;
RT   "RIG-G as a key mediator of the antiproliferative activity of interferon-
RT   related pathways through enhancing p21 and p27 proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:16448-16453(2006).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18706081; DOI=10.1186/ar2475;
RA   Huang X., Shen N., Bao C., Gu Y., Wu L., Chen S.;
RT   "Interferon-induced protein IFIT4 is associated with systemic lupus
RT   erythematosus and promotes differentiation of monocytes into dendritic
RT   cell-like cells.";
RL   Arthritis Res. Ther. 10:R91-R91(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-237, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-478, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=20686046; DOI=10.1128/jvi.00818-10;
RA   Schmeisser H., Mejido J., Balinsky C.A., Morrow A.N., Clark C.R., Zhao T.,
RA   Zoon K.C.;
RT   "Identification of alpha interferon-induced genes associated with antiviral
RT   activity in Daudi cells and characterization of IFIT3 as a novel antiviral
RT   gene.";
RL   J. Virol. 84:10671-10680(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH IFIT2.
RX   PubMed=21190939; DOI=10.1074/jbc.m110.207068;
RA   Stawowczyk M., Van Scoy S., Kumar K.P., Reich N.C.;
RT   "The interferon stimulated gene 54 promotes apoptosis.";
RL   J. Biol. Chem. 286:7257-7266(2011).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MAVS; TBK1; TRAF6 AND
RP   RIGI.
RX   PubMed=21813773; DOI=10.4049/jimmunol.1100963;
RA   Liu X.Y., Chen W., Wei B., Shan Y.F., Wang C.;
RT   "IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging
RT   MAVS and TBK1.";
RL   J. Immunol. 187:2559-2568(2011).
RN   [15]
RP   REVIEW.
RX   PubMed=20950130; DOI=10.1089/jir.2010.0101;
RA   Fensterl V., Sen G.C.;
RT   "The ISG56/IFIT1 gene family.";
RL   J. Interferon Cytokine Res. 31:71-78(2011).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH IFIT1 AND IFIT2.
RX   PubMed=21642987; DOI=10.1038/ni.2048;
RA   Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L.,
RA   Burkard T.R., Buerckstuemmer T., Stefanovic A., Krieger S., Bennett K.L.,
RA   Ruelicke T., Weber F., Colinge J., Mueller M., Superti-Furga G.;
RT   "IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.";
RL   Nat. Immunol. 12:624-630(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-478, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: IFN-induced antiviral protein which acts as an inhibitor of
CC       cellular as well as viral processes, cell migration, proliferation,
CC       signaling, and viral replication. Enhances MAVS-mediated host antiviral
CC       responses by serving as an adapter bridging TBK1 to MAVS which leads to
CC       the activation of TBK1 and phosphorylation of IRF3 and phosphorylated
CC       IRF3 translocates into nucleus to promote antiviral gene transcription.
CC       Exhibits an antiproliferative activity via the up-regulation of cell
CC       cycle negative regulators CDKN1A/p21 and CDKN1B/p27. Normally,
CC       CDKN1B/p27 turnover is regulated by COPS5, which binds CDKN1B/p27 in
CC       the nucleus and exports it to the cytoplasm for ubiquitin-dependent
CC       degradation. IFIT3 sequesters COPS5 in the cytoplasm, thereby
CC       increasing nuclear CDKN1B/p27 protein levels. Up-regulates CDKN1A/p21
CC       by down-regulating MYC, a repressor of CDKN1A/p21. Can negatively
CC       regulate the apoptotic effects of IFIT2. {ECO:0000269|PubMed:17050680,
CC       ECO:0000269|PubMed:20686046, ECO:0000269|PubMed:21190939,
CC       ECO:0000269|PubMed:21642987, ECO:0000269|PubMed:21813773}.
CC   -!- SUBUNIT: Component of an interferon-dependent multiprotein complex, at
CC       least composed of IFIT1, IFIT2 and IFIT3 (PubMed:21642987). Interacts
CC       with IFIT1 and IFIT2 (PubMed:21190939, PubMed:21642987). Interacts (via
CC       N-terminus) with MAVS, TBK1, TRAF6 and RIGI (PubMed:21813773).
CC       Interacts with COPS5 (PubMed:17050680). {ECO:0000269|PubMed:17050680,
CC       ECO:0000269|PubMed:21190939, ECO:0000269|PubMed:21642987,
CC       ECO:0000269|PubMed:21813773}.
CC   -!- INTERACTION:
CC       O14879; Q16543: CDC37; NbExp=4; IntAct=EBI-745127, EBI-295634;
CC       O14879; Q92905: COPS5; NbExp=4; IntAct=EBI-745127, EBI-594661;
CC       O14879; Q05D60: DEUP1; NbExp=4; IntAct=EBI-745127, EBI-748597;
CC       O14879; Q0P5U8: FLJ90650; NbExp=3; IntAct=EBI-745127, EBI-10226698;
CC       O14879; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-745127, EBI-2514791;
CC       O14879; P09914: IFIT1; NbExp=12; IntAct=EBI-745127, EBI-745117;
CC       O14879; Q5T764: IFIT1B; NbExp=6; IntAct=EBI-745127, EBI-3507164;
CC       O14879; P09913: IFIT2; NbExp=7; IntAct=EBI-745127, EBI-3507167;
CC       O14879; Q8IZ03: IFIT2; NbExp=4; IntAct=EBI-745127, EBI-746217;
CC       O14879; O14879: IFIT3; NbExp=3; IntAct=EBI-745127, EBI-745127;
CC       O14879; Q8IXX5: TMEM183A; NbExp=7; IntAct=EBI-745127, EBI-2841953;
CC       O14879; P09493-10: TPM1; NbExp=4; IntAct=EBI-745127, EBI-12123928;
CC       O14879; P06753: TPM3; NbExp=5; IntAct=EBI-745127, EBI-355607;
CC       O14879; Q5VU62: TPM3; NbExp=3; IntAct=EBI-745127, EBI-10184033;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17050680,
CC       ECO:0000269|PubMed:18706081}. Mitochondrion
CC       {ECO:0000269|PubMed:21813773}.
CC   -!- TISSUE SPECIFICITY: Expression significantly higher in peripheral blood
CC       mononuclear cells (PBMCs) and monocytes from systemic lupus
CC       erythematosus (SLE) patients than in those from healthy individuals (at
CC       protein level). Spleen, lung, leukocytes, lymph nodes, placenta, bone
CC       marrow and fetal liver. {ECO:0000269|PubMed:18706081}.
CC   -!- INDUCTION: By type I interferons, dsRNAs and viruses.
CC       {ECO:0000269|PubMed:17050680}.
CC   -!- SIMILARITY: Belongs to the IFIT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF026939; AAB95160.1; -; mRNA.
DR   EMBL; AF083470; AAC63524.1; -; mRNA.
DR   EMBL; U52513; AAB40606.1; -; mRNA.
DR   EMBL; BT007284; AAP35948.1; -; mRNA.
DR   EMBL; BC001383; AAH01383.1; -; mRNA.
DR   EMBL; BC004977; AAH04977.1; -; mRNA.
DR   CCDS; CCDS31241.1; -.
DR   CCDS; CCDS7402.1; -.
DR   RefSeq; NP_001026853.1; NM_001031683.4.
DR   RefSeq; NP_001540.2; NM_001549.5.
DR   PDB; 6C6K; X-ray; 2.54 A; C/D=416-459.
DR   PDBsum; 6C6K; -.
DR   AlphaFoldDB; O14879; -.
DR   SMR; O14879; -.
DR   BioGRID; 109660; 85.
DR   CORUM; O14879; -.
DR   DIP; DIP-37890N; -.
DR   FunCoup; O14879; 734.
DR   IntAct; O14879; 67.
DR   MINT; O14879; -.
DR   STRING; 9606.ENSP00000360876; -.
DR   GlyCosmos; O14879; 2 sites, 1 glycan.
DR   GlyGen; O14879; 3 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; O14879; -.
DR   PhosphoSitePlus; O14879; -.
DR   BioMuta; IFIT3; -.
DR   jPOST; O14879; -.
DR   MassIVE; O14879; -.
DR   PaxDb; 9606-ENSP00000360883; -.
DR   PeptideAtlas; O14879; -.
DR   ProteomicsDB; 48279; -.
DR   Pumba; O14879; -.
DR   Antibodypedia; 30262; 272 antibodies from 31 providers.
DR   CPTC; O14879; 1 antibody.
DR   DNASU; 3437; -.
DR   Ensembl; ENST00000371811.4; ENSP00000360876.4; ENSG00000119917.15.
DR   Ensembl; ENST00000371818.9; ENSP00000360883.4; ENSG00000119917.15.
DR   Ensembl; ENST00000679781.1; ENSP00000505987.1; ENSG00000119917.15.
DR   GeneID; 3437; -.
DR   KEGG; hsa:3437; -.
DR   MANE-Select; ENST00000371818.9; ENSP00000360883.4; NM_001549.6; NP_001540.2.
DR   AGR; HGNC:5411; -.
DR   CTD; 3437; -.
DR   DisGeNET; 3437; -.
DR   GeneCards; IFIT3; -.
DR   HGNC; HGNC:5411; IFIT3.
DR   HPA; ENSG00000119917; Low tissue specificity.
DR   MIM; 604650; gene.
DR   OpenTargets; ENSG00000119917; -.
DR   VEuPathDB; HostDB:ENSG00000119917; -.
DR   eggNOG; KOG1124; Eukaryota.
DR   GeneTree; ENSGT00950000182946; -.
DR   HOGENOM; CLU_043482_0_0_1; -.
DR   InParanoid; O14879; -.
DR   OMA; YLCHQIG; -.
DR   OrthoDB; 10043504at2759; -.
DR   PAN-GO; O14879; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; O14879; -.
DR   PathwayCommons; O14879; -.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   SignaLink; O14879; -.
DR   BioGRID-ORCS; 3437; 10 hits in 1152 CRISPR screens.
DR   ChiTaRS; IFIT3; human.
DR   GeneWiki; IFIT3; -.
DR   GenomeRNAi; 3437; -.
DR   Pharos; O14879; Tbio.
DR   PRO; PR:O14879; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; O14879; protein.
DR   Bgee; ENSG00000119917; Expressed in trigeminal ganglion and 194 other cell types or tissues.
DR   ExpressionAtlas; O14879; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0140374; P:antiviral innate immune response; IDA:UniProt.
DR   GO; GO:0051607; P:defense response to virus; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0009615; P:response to virus; IMP:UniProtKB.
DR   FunFam; 1.25.40.10:FF:000036; interferon-induced protein with tetratricopeptide repeats 5; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 3.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_rpt.
DR   PANTHER; PTHR10271; INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS; 1.
DR   PANTHER; PTHR10271:SF3; INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 3; 1.
DR   Pfam; PF13424; TPR_12; 1.
DR   Pfam; PF13176; TPR_7; 1.
DR   Pfam; PF13181; TPR_8; 2.
DR   SMART; SM00028; TPR; 5.
DR   SUPFAM; SSF48452; TPR-like; 2.
DR   PROSITE; PS50005; TPR; 5.
DR   PROSITE; PS50293; TPR_REGION; 1.
DR   neXtProt; NX_O14879; -.
DR   PharmGKB; PA29651; -.
DR   TreeFam; TF342671; -.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral defense; Cytoplasm; Immunity; Innate immunity;
KW   Mitochondrion; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat; TPR repeat.
FT   CHAIN           1..490
FT                   /note="Interferon-induced protein with tetratricopeptide
FT                   repeats 3"
FT                   /id="PRO_0000106349"
FT   REPEAT          51..84
FT                   /note="TPR 1"
FT   REPEAT          94..127
FT                   /note="TPR 2"
FT   REPEAT          136..169
FT                   /note="TPR 3"
FT   REPEAT          172..206
FT                   /note="TPR 4"
FT   REPEAT          207..240
FT                   /note="TPR 5"
FT   REPEAT          241..274
FT                   /note="TPR 6"
FT   REPEAT          415..448
FT                   /note="TPR 7"
FT   REPEAT          450..481
FT                   /note="TPR 8"
FT   REGION          467..490
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        474..490
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:20068231"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   CONFLICT        44
FT                   /note="F -> S (in Ref. 5; AAH04977)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359
FT                   /note="Q -> QQ (in Ref. 2; AAB40606)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        435
FT                   /note="Missing (in Ref. 2; AAB40606)"
FT                   /evidence="ECO:0000305"
FT   HELIX           417..428
FT                   /evidence="ECO:0007829|PDB:6C6K"
FT   HELIX           431..445
FT                   /evidence="ECO:0007829|PDB:6C6K"
FT   TURN            446..448
FT                   /evidence="ECO:0007829|PDB:6C6K"
FT   HELIX           453..457
FT                   /evidence="ECO:0007829|PDB:6C6K"
SQ   SEQUENCE   490 AA;  55985 MW;  B9F042D4DF7151D2 CRC64;
     MSEVTKNSLE KILPQLKCHF TWNLFKEDSV SRDLEDRVCN QIEFLNTEFK ATMYNLLAYI
     KHLDGNNEAA LECLRQAEEL IQQEHADQAE IRSLVTWGNY AWVYYHLGRL SDAQIYVDKV
     KQTCKKFSNP YSIEYSELDC EEGWTQLKCG RNERAKVCFE KALEEKPNNP EFSSGLAIAM
     YHLDNHPEKQ FSTDVLKQAI ELSPDNQYVK VLLGLKLQKM NKEAEGEQFV EEALEKSPCQ
     TDVLRSAAKF YRRKGDLDKA IELFQRVLES TPNNGYLYHQ IGCCYKAKVR QMQNTGESEA
     SGNKEMIEAL KQYAMDYSNK ALEKGLNPLN AYSDLAEFLE TECYQTPFNK EVPDAEKQQS
     HQRYCNLQKY NGKSEDTAVQ HGLEGLSISK KSTDKEEIKD QPQNVSENLL PQNAPNYWYL
     QGLIHKQNGD LLQAAKCYEK ELGRLLRDAP SGIGSIFLSA SELEDGSEEM GQGAVSSSPR
     ELLSNSEQLN
//
